FDBusiness.com

Evolva to Expand Nutritional Ingredients Portfolio With Abunda Acquisition

 Breaking News
  • Deliveroo to Make All Staff Shareholders Deliveroo, the leading food delivery company, has announced that it is to make all of its employees shareholders in the company and give them equity. The move will mean all permanent staff, present and future, will be given share options in the company. The move will be worth nearly £10 million for the majority of the [...]...
  • China’s Yoghurt and Cheese Markets Experience Steady High Value Retail Sales Growth While the overall dairy market in China is growing stably, the various categories are experiencing differing performance. New research from Mintel reveals that yoghurt and cheese are the market’s winning categories in recent years with yoghurt maintaining an annual retail sales growth of over 20% since 2014. Meanwhile, the cheese category has seen a growth [...]...
  • Tetra Pak® Extrusion Wheel Produces Stick Ice Cream Products With Large Inclusions at Highest Capacity Tetra Pak has launched an Extrusion Wheel that produces stick ice cream products with large-sized inclusions, such as whole nuts, real fruit segments, or cookie dough chunks at highest capacity on the market. The Tetra Pak® Extrusion Wheel, which can be added to existing lines, uses an innovative vertical rotating design that moves continuously at a [...]...
  • New Machine is UK First Rigid box specialist the Pollard Group has installed a bespoke magnet and ribbon loop inserting machine, the first of its kind in the UK. The £150,000 investment at Pollard’s factory in Enderby, Leicester is operating in conjunction with the company’s recently-installed Kolbus DA260 Casemaker to form a highly automated book jacket production department. In particular [...]...
  • Hi Europe & Ni Celebrates 10th Edition With Inspiring Events Programme Europe’s leading health, natural and nutrition show, Hi Europe & Ni, is celebrating its 10th edition with a move to a larger hall at Messe Frankfurt this year. From 27-29 November 2018, visitors will be able to access all of the show’s many features and live events under one roof. In addition, the Healthy Finished Products Expo [...]...

Evolva to Expand Nutritional Ingredients Portfolio With Abunda Acquisition

Evolva to Expand Nutritional Ingredients Portfolio With Abunda Acquisition
April 08
14:14 2011

Evolva, the Swiss pharmaceutical group, is expanding its innovative nutritional ingredients portfolio with the acquisition of R&D partner Abunda Nutrition, the US food ingredients business. Evolva and San Francisco-based Abunda have collaborated on the development of Abunda’s next-generation nutritional ingredients since 2009.

One part of this collaboration, using Evolva’s proprietary technology, succeeded in making the key components of the natural high intensity sweetener Stevia via fermentation in yeast. This process by-passes the complex logistics associated with the traditional cultivation, processing and refining of Stevia plants, and allows pure Stevia sweetness components to be produced.

The value of the global sweetener market is currently estimated at $70b per annum, with sugar the dominant product. Within this market, Stevia-based sweeteners are the fastest growing segment, with demand driven in part because Stevia extracts have 200-300 times the sweetness of sugar, but also because of increasing consumer demand for health, wellness, and performance products that are low-carbohydrate and low-sugar. By enabling the introduction of new sweetener products with compelling health, taste and other benefits for consumers, pure fermentation-derived Stevia components can potentially take an important part of the overall sweetener market.

In addition to Stevia, Evolva will obtain full ownership of certain additional development-stage compounds with relevance in cardiovascular health and other nutrition sectors. Clinical nutrition trials have been conducted on selected compounds.

Under the terms of the proposed merger, Evolva will acquire 100% of the share capital of Abunda in return for 25 million Evolva shares (12.9% of Evolva’s share capital post transaction, fully diluted).

“High-performance nutritional ingredients are becoming more valuable as both food and pharmaceutical companies seek better ways to deliver health benefits to consumers and patients around the world. We are excited by the commercial potential of the Stevia products we are developing together with Abunda and believe they create significant additional partnering opportunities for Evolva,” explains Neil Goldsmith, chief executive of Evolva. “We intend to commercialise Stevia following our established business-to-business model and expect to actively enter collaborations with companies regarding manufacturing scale-up and commercialisation. We believe products containing pure, fermentation derived Stevia components should be widely available in the next few years and that these will deliver winning combinations of health, taste and value to consumers around the world.”

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • May 21, 2018London Int'l Wine Fair
  • May 22, 2018European Coffee Expo
  • June 1, 2018Gluten Free Expo Slovakia
  • June 3, 2018Vinoble
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements